Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours Β· Estimated delivery Oct 19 - Oct 24
citalopram, fluoxetine, sertraline (anxiety and depression) Drugs metabolised by CYP450 2D6: Codeine (opioid painkiller) Inducers CYP450 2C19: Rifampicin (TB) Carbamazepine (epilepsy, trigeminal neuralgia) Inhibitors CYP450 2C19: Lansoprazole, omeprazole (reflex and heartburn) Drugs metabolised by CYP450 2C19: Warfarin (anticoagulant) Diazepam (sedative, anxiolytic) Phenytoin (epilepsy) Inducers CYP450 2C9: Rifampicin (TB) Carbamazepine (epilepsy, trigeminal neuralgia) Inhibitors CYP450 2C9: Miconazole (antifungal) Fluconazole (antifungal) Drugs metabolised by CYP450 2C9: Warfarin (anticoagulant) Non-steroidal anti-inflammatories Clopidogrel (antiplatelet) Genetical variations Genetic variations can lead to altered CYP450 polymorphisms and so altered metabolism of drugs
Larazotide is a peptide designed specifically to address intestinal permeability, commonly known as leaky gut. This condition occurs when the tight junctions in the intestinal lining loosen, allowing toxins, pathogens, and undigested food particles to escape into the bloodstream
Our products are sourced from GMP-certified facilities and tested for purity exceeding 99%
It is only available following a consultation and prescription from a licensed provider
FOXO4-DRI appears to work by inhibiting FOXO4-p53 binding
US$ 25.42
US$ 24.14
US$ 20.37
US$ 28.62
US$ 20.57
